Thai cannabis industries are browsing a speedy regulation shift period, and the operators who expected to meet the start are finding themselves better. “When new rules in GACP entered, we didn’t affect,” says Natcha Klahan, COO in the World Pharma Solutions. “But for many farms, it was a shock. It is a thing that passes the certificate, but it is a real role doing these standards day before day.”
Adherence to high rules from the beginning World Pharma has two GACP certified facilities near Bangkok: Samut Prakan’s high production area, and focused genetics at Samut Sakhon.
Samut Prakan delivers 160-180 kg flowers every three weeks. The farmhouse uses a vertical double tie incinerator, as the COCO substrate, with private climate automation and fertility through dosatron. “This site is built of reliability and volume,” explained Natchak. “We are able to produce consistently on a scale and maintain competitive costs while export standards are maintained.”
Coco, adds, is a practical opportunity for large-scale production in Thailand. “The substrate is more forgiveness.” With a strong Thai agricultural base, the Coco supply is not a problem, despite the global lack of this current media. “We promise about the baht of the top 200,000 Baht in Baht, and is not a shortage for us. We are a country of agriculture with coconut production.”
Samut Sakhon, stress houses produces 40-50 kg a week with a different crop philosophy. Here, the plants grow in Rockwool’s eight flowering rooms, managed by a small and specialized group of vineyards. “Rockwool is more suitable for craft approaches,” he explains. “Thai vines have a greater experience, especially those who have learned from American crop practice. The smaller bedroom allows us to run accurately.”
The site also has pheno-feno-hunting, mother stock and post-harvest processes. “We look for the strongest plants of mother, resistant to plague, not brittle, adaptable and high performance. That is the spine of everything we do,” he added. Homemade pathogen tests (HLV, fusarium) supports this program, with full climate control and well-managed drying and healing work flows.
The two facilities work completely inside LED lighting. With Natch, it has been a clear option: In a Thai climate, the internal crop provides full environmental control. To access European markets, strict microbial standards must be complied with, something difficult in external or greenhouse configurations, due to surprises and insect pressures.
Thai market developments Compared to business, the Thai cannabis sector is still at the beginning of the development phase. While the interest in dispensers in products like gums and editors are growing, the rules that require a prescription have affected the rhythm of retail growth. ‘Owners and operators live in different ways of market, so the perspectives can change as he asks,’ Natcha notes. After all, the winners do not see the regulations as obstacles, but as a basis for building permanent business models
His attitude, however, is clear: building international standards, although the demand for home remains uncertain. “Initially, I was looking at Europe and Canada as a model. Players who cut corners do not last long. For us, I had to fill it from one day to the next day.”
“The competitive advantage of Thailand lies in production costs, but the quality remains priority. Some non-compliance flowers made this year before, which does not meet farm rules,” Natcha says. “We want to show that Thailand can compete with international producers at the same quality level.”
Through the work done with a local association, Natcha is being pushed in Thailand to implement as a credible exporter. “We want to work with the government, not working against it. Compared to other countries. But if it hurts in Thailand’s popularity, the government will act quickly.
This is an illegal space for a sector that has the greatest importance was illegal and now is done to a standard that is not supported by error. “It takes years to destroy fame and minutes,” says natchak. “We have a long term. This means consistency, fulfilling and proving that Thailand can compete globally.”
For more information: World Pharma Solutions 98/20, 1 Bang Sao Tong Subdistrict, Bang Sao Thong District, Samut Prakan Province 10570, Thailand + 6662-718-6756 (Protected by email) worldpharmasolutions.com
After fifteen years of successful cooperation, managing director Moritz Böcking and the shareholders of Klasmann-Deilmann GmbH have mutually agreed to part ways. As of May 1, 2026, Moritz Böcking will hand over the position of managing director to Jan Astrup, who served as the company’s CEO in 2021/2022. Jan Astrup and Damian Ikemann will form the Board of Directors of the Klasmann-Deilmann Group from now on.
Klasmann-Deilmann thanks Moritz Böcking for his cooperation and the progress achieved in the transformation of the Klasmann-Deilmann Group. Moritz Böcking expanded Klasmann-Deilmann beyond the growing media business into new areas of commercial horticulture and promoted innovation and digitalization within the company. In addition, its achievements include the expansion of resources derived from renewable raw materials, as well as the acquisition of a subsidiary in Australia and production facilities in France and Canada, which operate in cooperation with external partners. He also significantly advanced Klasmann-Deilmann’s positioning as a global pioneer of sustainable development in the growing media industry, thereby making a decisive contribution to the company’s economic growth.
With Jan Astrup, Klasmann-Deilmann is getting an internationally experienced manager who has proven himself in the company and has extensive experience in raw materials, production, process optimization and technology. With the new CEO, raw materials and technology-driven areas for the substrate industry are now increasingly important at senior management level. Jan Astrup will strengthen the core commercial horticulture business and help develop the company for the future.
Rep. James Comer (R-KY) introduced the delay proposal as an amendment to the Farm Bill, while Rep. Mary Miller (R-IL) introduced an expedited approach. Neither will move forward, however, with Comer withdrawing his measure and the House Rules Committee failing to vote on Miller’s.
Hemp derivatives containing less than 0.3 percent delta-9 THC by weight of the drug were made federally legal under the 2018 Farm Bill signed by President Donald Trump in his first term. But late last year, Trump signed new legislation containing provisions that will redefine hemp so that only products with a total of 0.4 milligrams of THC per container will be legal starting Nov. 12.
Comer’s amendment, sponsored by Reps. Kelly Morrison (D-MN), Ilhan Omar (D-MN) and Morgan Griffith (R-VA), would have delayed the ban until November 2027.
According to Miller’s proposal, however, the ban will begin the day the new Farm Bill takes effect. However, it is unclear based on progress in Congress whether the large-scale farming legislation will actually become law, and the legislation could not pass until after the current recriminalization date.
Comer told the panel at Monday’s meeting that his amendment would “protect American farmers” and “help the hemp industry and the thousands of jobs that use and rely on these products.”
“It is clear that Congress needs more time to pass legislation that protects jobs, eliminates bad actors, standardizes labeling and requires third-party testing,” he said. “My amendment would give Congress another year, until November 2027, to develop this solution.”
It is not clear why he decided to remove it from the annex to the proposal Farm BillAlso known as the Farm, Food, and National Security Act of 2026, or HR 7567.
Griffith, a member of the Rules Committee who sponsored Comer’s amendment, noted that there are “a lot of hemp products from overseas that don’t have third-party testing” on the market, “frankly all kinds of junk.”
He said the real solution is for the Food and Drug Administration (FDA) to regulate the products, citing a separate bill he has introduced on the issue, but argued that “we have to have time to adjust,” which he said would provide the delay amendment.
Meanwhile, Rep. Andy Barr (R-KY) also introduced an amendment to the bill that, according to the sponsor’s summary, “changes the definition of hemp to protect the legal hemp market, creating a regulatory framework that protects children, bans synthetics, and ensures that products on the market are of American origin.”
The congressman later withdrew the proposal for undisclosed reasons.
Last week, Vince Haley, director of the White House Domestic Policy Council, and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Barr, who is helping lead efforts to establish regulations for the plant as an alternative to prohibition.
“We appreciate your work to advance policy,” the executive order Trump signed in December, which included provisions to protect Americans’ access to CBD products, the staff wrote in a letter to Congress.
“We are submitting draft legislation and comments to your account to address the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to adequate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks,” White House officials said, according to a social media screencast. “We are open to discussion and further technical assistance.”
The annex to the administration’s proposed legislative text has not been released publicly, and the White House and Barr’s office did not immediately respond to Marihuana Moment’s request for more details.
It’s not clear from the text of the letter whether the White House was proactively sending legislative proposals to the lawmaker or whether they were responding to something sent by his office, though two cannabis industry sources suggested to Marihuana Moment that Barr was sending the language to the administration, and then providing technical feedback.
“I’m calling on Congress to update the Act so Americans can continue to have access to the full-spectrum CBD products they trust and support, while maintaining Congress’ intent to restrict the sale of products that pose health risks,” the president said in a Truth Social message Thursday, the same day his administration announced it is moving forward to re-regulate marijuana.
“We need to do this RIGHT and FAST, especially for those who have found CBD to help them,” he said. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”
The Farm Bill passed by the previous committee includes provisions to help the hemp industry and farmers who grow cannabis for industrial purposes, such as fiber and grain. For example, the legislation would amend statutes related to states and tribes developing regulatory plans for industrial hemp production, including policies on testing, sampling, background checks and record keeping.
Other bipartisan hemp reform bills are pending in Congress.
Ernst withdrew his name, however, as a sponsor of the legislation. His office did not respond to Marihuana Moment’s request for clarification on the move.
As hemp products become more popular among consumers, some big brands are trying to get in on the action.
The main retailer Target, for example, is expanding its involvement in the hemp-derived THC beverage market. Last year, the company began a pilot program in 10 stores in Minnesota that sell cannabis drinks. That apparently went well, and now the company has secured licenses from Minnesota regulators to sell lower-potency edible hemp products — including THC drinks — in 72 stores in the state.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
North Carolina lawmakers say they’re fueling debate over the state’s marijuana laws — a move by the Trump administration to reclassify it as a less dangerous drug.
Across the country, a set of laws and enforcements regulate marijuana. The drug is illegal under federal law, but dozens of US states have legalized it. And almost all states have legalized medical marijuana prescriptions for certain ailments. North Carolina is among the remaining states to resist any form of legalization. Republican politicians in North Carolina have resisted passing any bills to legalize or decriminalize marijuana, despite public opinion polls showing broad public support for such changes.
Senate President Phil Berger said he expects his chamber to revisit efforts to legalize medical marijuana this week. “We will have a conversation within our caucus if they are interested in whether we do something,” Berger told reporters Tuesday.
The recent actions of Republican President Donald Trump may add a new dimension to these conversations. Trump’s acting attorney general on Thursday signed the drug classification as a less dangerous and less strictly regulated drug than marijuana. Federal law does not legalize marijuana for medical or recreational use.